These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1596 related articles for article (PubMed ID: 25884570)

  • 21. Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells.
    Luker KE; Lewin SA; Mihalko LA; Schmidt BT; Winkler JS; Coggins NL; Thomas DG; Luker GD
    Oncogene; 2012 Nov; 31(45):4750-8. PubMed ID: 22266857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis.
    Uygur B; Wu WS
    Mol Cancer; 2011 Nov; 10():139. PubMed ID: 22074556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The IL-8-regulated chemokine receptor CXCR7 stimulates EGFR signaling to promote prostate cancer growth.
    Singh RK; Lokeshwar BL
    Cancer Res; 2011 May; 71(9):3268-77. PubMed ID: 21398406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CXCR4 and CXCR7 Mediate TFF3-Induced Cell Migration Independently From the ERK1/2 Signaling Pathway.
    Dieckow J; Brandt W; Hattermann K; Schob S; Schulze U; Mentlein R; Ackermann P; Sel S; Paulsen FP
    Invest Ophthalmol Vis Sci; 2016 Jan; 57(1):56-65. PubMed ID: 26780310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer.
    Romain B; Hachet-Haas M; Rohr S; Brigand C; Galzi JL; Gaub MP; Pencreach E; Guenot D
    Mol Cancer; 2014 Mar; 13():58. PubMed ID: 24629239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells.
    Koch C; Fischer NC; Puchert M; Engele J
    BMC Cancer; 2022 Dec; 22(1):1335. PubMed ID: 36539774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis.
    Hernandez L; Magalhaes MA; Coniglio SJ; Condeelis JS; Segall JE
    Breast Cancer Res; 2011; 13(6):R128. PubMed ID: 22152016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CXCR7, CXCR4, and Their Ligand Expression Profile in Traumatic Brain Injury.
    Mousessian AS; Nunes da Silva CP; Oba-Shinjo SM; Kolias AG; Paiva WS; Nagahashi Marie SK
    World Neurosurg; 2021 Mar; 147():e16-e24. PubMed ID: 33189916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.
    Singh AK; Arya RK; Trivedi AK; Sanyal S; Baral R; Dormond O; Briscoe DM; Datta D
    Cytokine Growth Factor Rev; 2013 Feb; 24(1):41-9. PubMed ID: 22989616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging ligand-dependent activation of CXCR7.
    Luker KE; Gupta M; Steele JM; Foerster BR; Luker GD
    Neoplasia; 2009 Oct; 11(10):1022-35. PubMed ID: 19794961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential role of stromal cell-derived factor-1α/CXCR4/CXCR7 axis in adipose-derived mesenchymal stem cells.
    Ji F; Wang Y; Yuan J; Wu Q; Wang J; Liu D
    J Cell Physiol; 2020 Apr; 235(4):3548-3557. PubMed ID: 31566725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
    Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
    J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Common structural interactions between the receptors CXCR3, CXCR4 and CXCR7 complexed with their natural ligands, CXCL11 and CXCL12, by a modeling approach.
    Costantini S; Raucci R; De Vero T; Castello G; Colonna G
    Cytokine; 2013 Oct; 64(1):316-21. PubMed ID: 23773308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells.
    Ieranò C; Santagata S; Napolitano M; Guardia F; Grimaldi A; Antignani E; Botti G; Consales C; Riccio A; Nanayakkara M; Barone MV; Caraglia M; Scala S
    Cell Death Dis; 2014 Jul; 5(7):e1310. PubMed ID: 24991762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies.
    Daniel SK; Seo YD; Pillarisetty VG
    Semin Cancer Biol; 2020 Oct; 65():176-188. PubMed ID: 31874281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR.
    Circelli L; Sciammarella C; Guadagno E; Tafuto S; del Basso de Caro M; Botti G; Pezzullo L; Aria M; Ramundo V; Tatangelo F; Losito NS; Ieranò C; D'Alterio C; Izzo F; Ciliberto G; Colao A; Faggiano A; Scala S
    Oncotarget; 2016 Apr; 7(14):18865-75. PubMed ID: 26934559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The disparate twins: a comparative study of CXCR4 and CXCR7 in SDF-1α-induced gene expression, invasion and chemosensitivity of colon cancer.
    Heckmann D; Maier P; Laufs S; Li L; Sleeman JP; Trunk MJ; Leupold JH; Wenz F; Zeller WJ; Fruehauf S; Allgayer H
    Clin Cancer Res; 2014 Feb; 20(3):604-16. PubMed ID: 24255072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
    Khare T; Bissonnette M; Khare S
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma.
    Liberman J; Sartelet H; Flahaut M; Mühlethaler-Mottet A; Coulon A; Nyalendo C; Vassal G; Joseph JM; Gross N
    PLoS One; 2012; 7(8):e43665. PubMed ID: 22916293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring the CXCR4/CXCR7/CXCL12 Axis in Primary Desmoid Tumors.
    Baccalini EA; Renne SL; Colombo P; Pasqualini F; Quagliuolo VL; Cananzi FCM; Grizzi F; Borroni EM
    Anticancer Agents Med Chem; 2023; 23(20):2248-2253. PubMed ID: 36748819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 80.